Phospholipid transfer protein
Phospholipid Transfer Protein (PLTP) is a protein that plays a critical role in lipid metabolism, particularly in the transfer of phospholipids between lipoproteins. It is involved in the process of high-density lipoprotein (HDL) remodeling, which is essential for the reverse cholesterol transport pathway. This pathway is significant for the maintenance of cellular lipid homeostasis and the prevention of atherosclerosis. PLTP is also involved in the inflammatory response and has been implicated in several diseases related to lipid metabolism disorders.
Function[edit | edit source]
PLTP facilitates the transfer of phospholipids from triglyceride-rich lipoproteins (such as VLDL and chylomicrons) to HDL particles. This action is crucial for the maturation of HDL particles and their capacity to participate in reverse cholesterol transport, a process by which excess cholesterol is removed from tissues and transported to the liver for excretion. PLTP activity affects the size and composition of HDL particles and influences the overall process of lipid metabolism and transport in the body.
Clinical Significance[edit | edit source]
Alterations in PLTP activity have been associated with several metabolic disorders, including obesity, diabetes mellitus, and cardiovascular disease. High levels of PLTP activity can lead to reduced HDL cholesterol levels and impaired reverse cholesterol transport, which are risk factors for atherosclerosis. Conversely, low PLTP activity can also have detrimental effects, highlighting the importance of balanced PLTP activity for cardiovascular health.
Genetics[edit | edit source]
The gene encoding the phospholipid transfer protein is located on chromosome 20 in humans. Variations in this gene have been studied for their potential impact on PLTP activity and their association with lipid levels and cardiovascular disease risk.
Research Directions[edit | edit source]
Research on PLTP continues to explore its role in lipid metabolism and its potential as a therapeutic target for treating lipid-related disorders. Inhibitors of PLTP activity are being investigated for their ability to improve lipid profiles and reduce the risk of atherosclerosis. Additionally, the role of PLTP in other physiological processes and diseases, such as inflammation and obesity, is an area of active investigation.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD